Literature DB >> 1846828

Role of glucose, insulin, and glucagon in glycogen mobilization in human hepatocytes.

M Pilar López1, M J Gómez-Lechón, J V Castell.   

Abstract

This study investigated the role of glucose, insulin, and glucagon in the activation of glycogen catabolism in cultured human hepatocytes. Basal glycogenolysis in unstimulated human hepatocytes was low (only 19% of initial glycogen content was degraded in a 4-h incubation) and insensitive to changes in external glucose concentration (from 10 to 0 mM). Both glycogenolysis and glucose output could be significantly stimulated by 35 ng/L glucagon or 10(5) pM dibutyryl cAMP; half-maximal effect was found with 28 x 10(2) ng/L glucagon and 4 x 10(5) pM dibutyryl cAMP. After a 3-h exposure to 35 x 10(3) ng/L glucagon, greater than 90% of glycogen content of human hepatocytes was mobilized. This caused a 4.6-fold increase in the rate of glucose output to the medium compared with nonstimulated cells. About 85% of degraded glycogen rendered glucose to the medium. Insulin (10(4) pM) was able to totally suppress basal glycogenolysis; insulin was also essential to reverse the action of glucagon in hepatocytes incubated with glucagon, whereas glucose alone, even at postprandial concentration, was unable to reverse glucagon action. In summary, these experiments show that the mobilization of glycogen stores of human hepatocytes, as it occurs during the postabsorptive periods in humans, is largely dependent on the presence of glucagon and is not simply due to a decrease of external glucose. Insulin, on the other hand, was essential to suppress both basal and glucagon-activated glycogenolysis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1846828     DOI: 10.2337/diabetes.40.2.263

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  3 in total

Review 1.  Stable liquid glucagon formulations for rescue treatment and bi-hormonal closed-loop pancreas.

Authors:  Melanie A Jackson; Nicholas Caputo; Jessica R Castle; Larry L David; Charles T Roberts; W Kenneth Ward
Journal:  Curr Diab Rep       Date:  2012-12       Impact factor: 4.810

2.  Glucagon lowers glycemia when β-cells are active.

Authors:  Megan E Capozzi; Jacob B Wait; Jepchumba Koech; Andrew N Gordon; Reilly W Coch; Berit Svendsen; Brian Finan; David A D'Alessio; Jonathan E Campbell
Journal:  JCI Insight       Date:  2019-07-23

Review 3.  Endothelial Cell Glucose Metabolism and Angiogenesis.

Authors:  Wa Du; Lu Ren; Milton H Hamblin; Yanbo Fan
Journal:  Biomedicines       Date:  2021-02-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.